Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-21-326210
Filing Date
2021-11-10
Accepted
2021-11-10 17:19:07
Documents
9
Effectiveness Date
2021-11-10

Document Format Files

Seq Description Document Type Size
1 S-3ASR d228470ds3asr.htm S-3ASR 450145
2 EX-1.2 d228470dex12.htm EX-1.2 185893
3 EX-4.4 d228470dex44.htm EX-4.4 279182
4 EX-4.5 d228470dex45.htm EX-4.5 283069
5 EX-5.1 d228470dex51.htm EX-5.1 17233
6 EX-5.2 d228470dex52.htm EX-5.2 8244
7 EX-23.1 d228470dex231.htm EX-23.1 1503
8 GRAPHIC g228470g1109114821191.jpg GRAPHIC 2632
9 GRAPHIC g228470g27c93.jpg GRAPHIC 34576
  Complete submission text file 0001193125-21-326210.txt   1274371
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-260972 | Film No.: 211397873
SIC: 2836 Biological Products, (No Diagnostic Substances)